Oct 29, 2026 earnings call — Repricing improved insurance costs and sales momentum
TriNet kept full-year guidance and said adjusted earnings per diluted share are tracking at the high end of $4.50 to $5.10, toward $5.10.
Revenue $1.2B (est $1.2B) · EPS $0.94 (est $0.60)
Key quotes
"After completing our repricing efforts, insurance performance has improved, and once again in Q3, it was better than forecast and within our target ICR range."
"At the end of the third quarter, nearly 60% of WSE-initiated chats are being resolved using AI, freeing our colleagues to solve more complex requests with greater speed."
"New sales ACV for Q3 grew mid-single digits year over year, representing further improvement in our sales trajectory."
Analyst Q&A 5
Q1 sales and hiring impact
Q (Jared Levine · TD Cowen): How do you feel about Q1 sales given the current pipeline and planned sales hiring? Also asked for context on Q4 acceleration and sustainability.
A: Management said momentum is building and they feel confident about high single digit sales growth in Q4. They noted the January pipeline needs work over the next six to seven weeks but they expect to build on second-half momentum supported by the Ascend program and broker channel progress.
"I think we are in a spot we can feel pretty confident about high single digits in Q4." — Mike Simonds (CEO)
Renewals, retention, and ICR drivers
Q (Dan · William Blair): How are renewals and retention looking this fall selling season and into 2027? Also asked how much of this year's ICR improvement comes from market conditions versus internal actions.
A: Management said retention bounced back after catch-up repricing and they expect retention to be better than historical average as they place January renewals. They said the long-term ICR target is 87%-90% and in this high-inflation period they are targeting the top end of that range; they would not provide a 2027 ICR outlook and noted a one-time Q2 settlement benefit and expected pharma trends may reassert.
"We've talked about a long-term target for the insurance cost ratio overall being in that 87%-90% range." — Mike Simonds (CEO)
Q4 EPS drivers and WSE outlook
Q (Ross Cole · Needham & Company): What is driving the step down in EPS for Q4, and can you give more color on retention and new sales growth for WSE in 2027?
A: Management reiterated full-year adjusted EPS guidance and said they expect to be at the top end of the range at $5.10, driven by a Q3 beat and some reinvestment of that beat into strategic initiatives. They said retention has recovered toward and above historical levels after early-year repricing, client NPS is high, and they expect midterm retention and sustainable new sales growth to improve but would not peg 2027 exactly.
"When we gave guidance in July, where we talked about our adjusted EPS in the range of $4.50 to $5.10, we have reiterated that guidance this morning." — Mala Murthy (CFO)
Competitive position after repricing
Q (David Grossman · Stifel): Now that most of the book has been repriced, how should we think about competitive positioning if healthcare costs stay elevated? Also asked about effects on participation and plan choices.
A: Management said they have improved pricing, processes, and models and will remain disciplined; they do not see a dramatic competitive shift but note some larger private players are growing. They expect a little downward pressure on participation, some clients may move to self- or level-funded plans as they grow, and they have product bundle changes to help clients hit price points; taking risk lets them reprice cohorts quarterly versus annual pass-through models.
"Well, I think because we take risk, then another dynamic, David, I know you're familiar with is we're repricing a cohort of our business every quarter." — Mike Simonds (CEO)
Drivers of retention improvement
Q (Tyler Barishaw · Truist): You mentioned retention is modestly improving. What are the drivers of that improvement?
A: Management said the early-year attrition was largely driven by catch-up health fee increases, and now that health fees are more in line with current trend, retention has improved. They also pointed to record NPS and continued service investments that increase client stickiness and aim to raise retention over the midterm.
"Earlier in the year, as we were talking through those results, the health fee increases, when we looked at reasons for attrition, that was far and away our biggest driver." — Mike Simonds (CEO)